Extens
Extens is a Paris-based private equity firm founded in 2014 by Arnaud Houette and Quentin Jacomet dedicated EXCLUSIVELY to healthcare software companies in France and Western Europe. SIREN 840654818 SAS HQ 250 B Rue du Faubourg Saint-Honore 75008 Paris with 14 staff including 4 partners. Tickets EUR 2-15M for SMEs generating EUR 3-20M revenue with at least 50 percent recurring software revenue and a positive EBITDA. Extens manages around EUR 200M across three vintages (Extens I 2014 ~EUR 30M + Extens II 2018 ~EUR 65M + Extens III 2022 EUR 106M Healthcare Software and Data). Notable exits include Enovacom 2018 to Orange Business Services + Discngine 2022 to Chemical Computing Group + Must Informatique and Teranga both 2024 to Orisha + Horizontal Software January 2026 to Octime Group. First non-France investment Medicore Netherlands October 2024.
Key facts
Recent exits
Coverage notes
3 funds tracked, 27 portfolio companies (19 active · 8 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Extens has raised, with its portfolio companies. Hand-checked from public filings.
Extens IIIGrowth2022 · 4yr€106M7 active · 1 realized
Unrealized
7 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Canal Santé | Healthcare | France | 2022 |
| Imagine Human | Software | France | 2023 |
| Medelse | Healthcare | France | 2022 |
| Medicore | Healthcare | Netherlands | 2024 |
| Optacare | Healthcare | France | 2022 |
| SignalSoft Développement | Healthcare | France | 2026 |
| Val Solutions | Healthcare | France | 2023 |
Extens IIGrowth2018 · 8yr€65M11 active · 3 realized
Unrealized
11 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| BMI System | Software | France | 2021 |
| Bow Medical | Healthcare | France | 2018 |
| Cegape | Software | France | 2021 |
| Coptis | Software | France | 2021 |
| HOPPEN | Healthcare | France | 2019 |
| IntecMedia | Healthcare | France | 2021 |
| Keenturtle | Software | France | 2021 |
| MediReport | Healthcare | France | 2020 |
| Sancare | Software | France | 2018 |
| Sanilea | Healthcare | France | 2019 |
| Ubaq | Healthcare | France | 2020 |
Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Horizontal Software | Software | France | 2020 | 2026 | Trade Sale | – | |
| Sofia Développement | Healthcare | France | 2019 | 2026 | Trade Sale | – | |
| Teranga | Healthcare | France | 2018 | 2024 | Trade Sale | – |
Extens IGrowth2014 · 12yr€30M1 active · 4 realized
Unrealized
1 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Kayentis | Healthcare | France | 2015 |
Realized
4 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Discngine | Software | France | 2017 | 2022 | Trade Sale | – | |
| Enovacom | Healthcare | France | 2014 | 2018 | Trade Sale | – | |
| Must Informatique | Healthcare | France | 2017 | 2024 | Trade Sale | – | |
| SNAL | Healthcare | France | 2017 | 2019 | Secondary | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Extens
Extens is a private equity firm with capital deployed across 2 active fund vehicles and a founding year of 1993, headquartered in Paris. The platform targets majority and significant minority stakes in European mid-cap businesses across software and healthcare, deploying institutional capital from successive flagship vehicles.
Investment thesis
The platform deploys buyout and growth equity capital across software and healthcare businesses in France and selectively across Europe, targeting majority and significant minority equity positions in mid-cap and lower mid-cap European companies. Value-creation framework emphasises operational improvement, working capital optimisation and selective M&A activity, with the partnership culture supporting management teams across multi-year ownership periods.
Recent activity
Recent realised exits include Horizontal Software (software, 2021). The platform tracks 2 fund vehicles, 25 active portfolio companies and 1 realised exit across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.